The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age

Turner, David A. ORCID: https://orcid.org/0000-0002-1689-4147, Wailoo, Allan J., Cooper, Nicola J., Sutton, Alex J., Abrams, Keith R. and Nicholson, Karl G. (2006) The cost-effectiveness of influenza vaccination of healthy adults 50–64 years of age. Vaccine, 24 (7). pp. 1035-1043. ISSN 1873-2518

Full text not available from this repository. (Request a copy)

Abstract

Influenza can cause significant morbidity and mortality. Influenza vaccination is an effective and safe strategy in the prevention of influenza. Currently the National Health Service (NHS) vaccinates ‘at-risk’ individuals only. This definition includes everyone over 65 years of age but excludes individuals 50–64 years of age unless they have an additional risk factor, such as underlying heart disease or lung disease. In order to examine the cost-effectiveness of an extension of the vaccination policy to include this age group we constructed an economic model to estimate the costs and benefits of vaccination from both a health service and a societal perspective. Data to populate the model was obtained from the literature and the outcome measure used was the quality adjusted life year (QALY). Influenza vaccination prevented an estimated 4508 cases (95% CI: 2431–7606) per 100,000 vaccinees per influenza season for a net cost to the NHS of £653,221 (95% CI: 354,575–1,072,257). The net cost increased to £1,139,069 (95% CI 27,052–2,030,473) when non-NHS costs were included and the estimated cost-per-QALY were £6174 and £10,766 for NHS and all costs respectively. Extension of the current immunisation policy has the potential to generate a significant health benefit at a comparatively low cost.

Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit
Faculty of Medicine and Health Sciences > Research Groups > Health Services and Primary Care
Faculty of Medicine and Health Sciences > Research Groups > Health Economics
Faculty of Medicine and Health Sciences > Research Centres > Population Health
Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User: Users 2731 not found.
Date Deposited: 05 Dec 2012 12:22
Last Modified: 15 Mar 2024 16:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/40401
DOI: 10.1016/j.vaccine.2004.12.033

Actions (login required)

View Item View Item